BUY MBP SORAFENIB TOSYLATE SORANIB 200MG TAB 120`S BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Sorafenib tosylate is an oral anticancer medicine used to treat certain advanced cancers, most commonly hepatocellular carcinoma (primary liver cancer), renal cell carcinoma (kidney cancer), and some types of thyroid cancer. Sorafenib tosylate belongs to a group of medicines called multikinase inhibitors. It works by blocking specific enzymes and signalling pathways that cancer cells use to grow, divide, and form new blood vessels. By interfering with these processes, sorafenib tosylate helps slow tumour growth and limits the blood supply that cancer cells need to survive.

Sorafenib tosylate works in two main ways. First, it blocks signals inside cancer cells that promote uncontrolled growth and division. Second, it blocks the formation of new blood vessels that supply oxygen and nutrients to tumours. This dual action helps slow the progression of cancer and, in some patients, reduces tumour size or stabilises the disease. Because of this mechanism, sorafenib tosylate is particularly useful in cancers that rely heavily on new blood vessel formation.

Sorafenib tosylate is taken by mouth, usually twice daily, and should be taken on an empty stomach, either at least one hour before or two hours after eating. The tablets should be swallowed whole with water and not crushed or chewed. It is important to take sorafenib tosylate at the same times each day to maintain steady levels of the medicine in the body. Treatment is often long-term and continues as long as the cancer responds and side effects remain manageable.

While taking sorafenib tosylate, regular monitoring is required. Blood tests are done to check liver function, kidney function, and electrolyte levels. Blood pressure is also monitored closely, as sorafenib tosylate can cause or worsen high blood pressure. Your healthcare team may adjust your dose if side effects become difficult to manage.

Common side effects of sorafenib tosylate include fatigue, diarrhoea, loss of appetite, weight loss, nausea, and abdominal discomfort. Skin reactions are very common, especially a condition known as hand?foot skin reaction, which causes redness, pain, swelling, or peeling of the palms and soles. Early treatment with moisturisers, protective footwear, and dose adjustments can help manage this side effect effectively.

Sorafenib tosylate can also cause changes in the skin such as rash, dryness, or hair thinning. Some people experience mouth sores or voice changes. High blood pressure is another common side effect, particularly during the early weeks of treatment, and may require medication to control it.

More serious side effects can occur, although they are less common. These include bleeding, delayed wound healing, heart problems such as chest pain or reduced heart function, and liver injury. Signs such as yellowing of the skin or eyes, dark urine, severe fatigue, chest pain, or shortness of breath should be reported immediately.

Sorafenib tosylate may increase the risk of bleeding and should be used cautiously in people taking blood thinners or those with bleeding disorders. It may also interfere with wound healing, so it is often stopped before planned surgery and restarted afterward under medical supervision.

Drug interactions can occur with sorafenib tosylate. Certain antibiotics, antifungal medications, seizure medicines, and herbal products such as St John?s wort can reduce its effectiveness or increase side effects. Grapefruit and grapefruit juice should be avoided, as they can increase drug levels in the body.

Sorafenib tosylate should not be used during pregnancy, as it may harm an unborn baby. Effective contraception is required during treatment and for a period after stopping the medication. Breastfeeding is not recommended while taking sorafenib tosylate.

Although sorafenib tosylate does not cure cancer, it can significantly slow disease progression and help control symptoms. Many patients are able to continue daily activities while on treatment, with appropriate monitoring and supportive care. Regular follow-up appointments are essential to ensure treatment remains safe and effective.